Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.64 |
| ▸ | LPL | P06858 | 12/20 | 0.64 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10060182 | 0.88 | LPL (0.46) | LIPGLPLCSF1RCA1CA2 | |
| SCHEMBL13331256 | 0.86 | LPL (0.45) | LIPGLPLCSF1RIRAK4KDM4E | |
| SCHEMBL30008861 | 0.85 | LIPG (0.78) | LIPGLPLSNCAALDH1A1HPGD | |
| SCHEMBL19106673 | 0.85 | LIPG (0.78) | LIPGLPLSNCAALDH1A1HPGD | |
| SCHEMBL13331252 | 0.84 | LPL (0.43) | LIPGLPLCSF1RIRAK4KDM4E | |
| SCHEMBL27026503 | 0.82 | LIPG (0.68) | LIPGLPLIRAK4ESR1ESR2 | |
| SCHEMBL4470995 | 0.81 | LIPG (0.71) | LIPGLPLSNCACA1CA2 | |
| SCHEMBL12654466 | 0.79 | LPL (0.54) | LIPGLPLCSF1RCA1CA2 | |
| SCHEMBL6126262 | 0.79 | LPL (0.53) | LIPGLPLCSF1RCA1CA2 | |
| SCHEMBL23956366 | 0.78 | LIPG (0.69) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023427-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CCNL2, AHR, ARNT | LIPG 3077/4885LPL 2919/4885SNCA 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.